Thiazolidinediones increase hepatic insulin extraction in African Americans with impaired glucose tolerance and type 2 diabetes mellitus. A pilot study of rosiglitazone-Reference-Cited by-同舟云学术

Thiazolidinediones increase hepatic insulin extraction in African Americans with impaired glucose tolerance and type 2 diabetes mellitus. A pilot study of rosiglitazone

Published:2007-01 Issue:1 Volume:56 Page:24-29
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Osei Kwame,Gaillard Trudy,Schuster Dara

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference22 articles.

1. Rosiglitazone amplifies the benefits lifestyle intervention measures in long-term, type 2 diabetes mellitus;Renynolds;Diabetes Obes Metab,2002

2. Metabolic effects of chronic glipizide gastrointestinal therapeutic system on serum glucose, insulin secretion, insulin sensitivity, and hepatic insulin extraction in glucose-tolerant, first-degree relatives of African American patients with type 2 diabetes: New insights on mechanisms of action

3. Effects of rosiglitazone on plasma adiponectin, insulin sensitivity and insulin secretion in African Americans with impaired glucose tolerance and type 2 diabetes;Osei;Metabolism,2004

4. Preservation of pancreatic beta cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high risk Hispanic women;Buchanan;Diabetes,2002

5. The impact of an insulin sensitizer, troglitazone, on glucose metabolism in African Americans at risk for type 2 diabetes mellitus: a placebo-controlled, 24-month randomized study;Schuster;Metabolism,2003

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PPAR agonists as add-on treatment with metformin in management of type 2 diabetes: a systematic review and meta-analysis;Scientific Reports;2024-04-16

2. Lipids and ketones dominate metabolism at the expense of glucose control in pulmonary arterial hypertension: a hyperglycaemic clamp and metabolomics study;European Respiratory Journal;2020-02-27

3. Association of increased hepatic insulin clearance and change in serum triglycerides or β‐hydroxybutyrate concentration via the sodium/glucose‐cotransporter 2 inhibitor tofogliflozin;Diabetes, Obesity and Metabolism;2020-02-14

4. COMBINED TREATMENT WITH SAXAGLIPTIN PLUS DAPAGLIFLOZIN REDUCES INSULIN LEVELS BY INCREASED INSULIN CLEARANCE AND IMPROVES β-CELL FUNCTION;Endocrine Practice;2017-03

5. Racial and Ethnic Disparities in Prevalence and Care of Patients With Type 2 Diabetes;Clinical Diabetes;2017-01-01